Real-time enrollment status for this adhd clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06431256 |
| Recruiting Status | Terminated |
| Condition | ADHD |
| Phase | Clinical Trial |
| Target Enrollment | 168 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Ironshore Pharmaceuticals and Development, Inc |
| Last Updated on CT.gov | November 6, 2025 (Nov 6, 2025) |
As of March 2, 2026: Clinical trial NCT06431256 is currently terminated participants. This clinical trial study for adhd is not currently accepting new participants at 13 locations across the United States. The study is sponsored by Ironshore Pharmaceuticals and Development, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06431256 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06431256 was last updated Nov 6, 2025 (November 6, 2025). HelloStudys verifies this status automatically.